An innovative study showed that there is a risk of a possible decreased fertility in ovarian cancer patients treated with radioactive iodine treatment.
European regulators have recommended conditional approval for daratumumab, an immunotherapy treatment for multiple myeloma.
Cobimetinib in combination with vemurafenib found to be even more beneficial than cobimetinib alone for melanoma patients, a new study reports.
A new analysis reveals that men with advanced melanoma benefited from a combination treatment of dabrafenib and trametinib.
Female childhood cancer survivors are more likely to have children than male survivors, a new study reveals.
Removing the second, healthy breast rose from 4% in breast cancer patients in 2002 to nearly 13% in 2012. However, this removal will not reduce the risk of dying.
Patients with head and neck cancer who underwent PET/CT-guided surveillance or planned neck dissection had similar survival rates.
Targeted therapy options can treat difficult to treat cancer tumors regardless of where tumor first originated with genomic profiling, a new study reveals.
Abiraterone acetate increased overall survival in men with early and less aggressive chemotherapy-naïve metastatic castration-resistant prostate cancer.
Genomic testing can be used to help accurately select early breast cancer patients who can safely be spared chemotherapy, a new study shows.
US regulators approved crizotinib capsules for the treatment of metastatic non-small cell lung cancer.
Cancer patients experiencing chemotherapy-induced neuropathy after chemotherapy improved their quality of life and reduced pain using neurofeedback.
A meta-analysis revealed that dose-dense adjuvant chemotherapy significantly improved overall survival in premenopausal women with breast cancer.
Tumors of breast cancer patients either shrunk or disappeared after treatment with a combination of lapatinib and trastuzumab.
Focusing postoperative radiotherapy around tumor containing cells has fewer long-term side effects and low recurrence rate in breast cancer patients.
A retrospective study reports that a high white blood cell ratio in early stage breast cancer patients is linked to an increased risk of disease recurrence.
A new study reports that undergoing double mastectomy did not improve the quality of life of breast cancer patients.
Bladder cancer patients who underwent surgery were found to be at risk due to blood clots formed in their vein after hospital discharge.
RFA was found to complement immunotherapy and induce systemic antitumor responses in colorectal cancer patients with liver metastasis.
Scientists were able to see whether a patient with advanced melanoma skin cancer is relapsing by tracking levels of circulating tumor DNA in the blood.
A new large study reported that the location where prostate cancer spreads has an impact on the patient’s survival time.
Advanced urothelial cancer patients treated with ramucirumab plus docetaxel as second-line treatment reduced disease progression risk, a new study shows.
Mapping a patient’s family health history helped identify at-risk patients leading them to timely screening while saving others from unnecessary monitoring tests.
A new study of the association between moles and tumor thickness found that having less moles is associated with reduced risk for thick melanoma.
Melanoma rates have doubled although today we have more tools than even to diagnose melanoma, including genetic and molecular testing.
US regulators have approved obinutuzumab in combination with bendamustine followed by obinutuzumab monotherapy for the treatment of patients with follicular lymphoma.
Childhood Hodgkin's lymphoma survivors are at risk of breast cancer say researchers, adding that early screening reduces risk of breast cancer death.
Patients of advanced lung or colorectal cancer want to receive better information on genomics and DNA sequencing results, a new study shows.
US regulators approved earlier than scheduled palbociclib in combination with fulvestrant for the treatment of some cases of breast cancer.
Cancer patients with symptoms of depression before undergoing a complex abdominal surgery are more likely to have postoperative complications, a study finds.